UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Journal of biological chemistry, ISSN 0021-9258, 10/2005, Volume 280, Issue 43, pp. 36529 - 36540
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Laminin - pharmacology | Neoplasm Transplantation | Prostatic Neoplasms - metabolism | Cell Proliferation | Humans | Extracellular Matrix - metabolism | Collagen - chemistry | Immunoblotting | Male | Proteoglycans - chemistry | Neoplasm Metastasis | Transfection | RNA Interference | Time Factors | Collagen - pharmacology | Prostatic Neoplasms - pathology | Signal Transduction | Cell Survival | Neoplasm Invasiveness | Electrophoresis, Polyacrylamide Gel | Gene Silencing | Tetrazolium Salts - pharmacology | Urokinase-Type Plasminogen Activator - genetics | Reverse Transcriptase Polymerase Chain Reaction | Plasmids - metabolism | Animals | Mitogen-Activated Protein Kinase 3 - metabolism | Proteoglycans - pharmacology | Urokinase-Type Plasminogen Activator - metabolism | Mice, Nude | Cell Line, Tumor | Laminin - chemistry | Mice | Thiazoles - pharmacology | Neoplasms - pathology | Drug Combinations | Microscopy, Fluorescence | Apoptosis | Mitogen-Activated Protein Kinase 1 - metabolism | RNA, Small Interfering - metabolism | Index Medicus | RNAi | uPAR (uPA receptor) | shRNA (small hairpin RNA) | uPA (urokinaseplasminogen activator) | survival | siRNA (small interfering RNA) | prostate cancer | invasion | uPA and uPAR | ANOVA (analysis of variance) | RNAi (RNA interference) | RT (reverse transcription) | TPBS (tween-20 (0.1%) phospate buffered saline) | BSA (bovine serum albumin)
Journal Article
Oncogene, ISSN 0950-9232, 05/2013, Volume 32, Issue 18, pp. 2282 - 2291
CFTR | miR-193b | uPA | Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Prostatic Neoplasms - metabolism | Receptors, Urokinase Plasminogen Activator - immunology | Humans | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Male | Cell Movement - genetics | Gene Knockdown Techniques | Prostatic Neoplasms - genetics | Base Sequence | Female | Urokinase-Type Plasminogen Activator - immunology | Prostatic Neoplasms - pathology | Down-Regulation | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | Urokinase-Type Plasminogen Activator - genetics | Receptors, Urokinase Plasminogen Activator - metabolism | Xenograft Model Antitumor Assays | Animals | Urokinase-Type Plasminogen Activator - metabolism | Mice, Nude | Cell Line, Tumor | Cystic Fibrosis Transmembrane Conductance Regulator - genetics | Mice | MicroRNAs - genetics | Receptors, Urokinase Plasminogen Activator - genetics | Urokinase | Tissue plasminogen activator | Physiological aspects | Development and progression | Tumor suppressor genes | Genetic aspects | Research | Prostate cancer | Cystic fibrosis | Membranes | Tumors | Index Medicus
Journal Article
BMC cancer, ISSN 1471-2407, 07/2008, Volume 8, Issue 1, pp. 194 - 194
Life Sciences & Biomedicine | Oncology | Science & Technology | Predictive Value of Tests | CA-19-9 Antigen - genetics | Prognosis | Adenoma, Villous - diagnosis | Carcinoembryonic Antigen - blood | Cathepsin B - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Carcinoembryonic Antigen - genetics | Male | Adenoma, Villous - blood | Cathepsins - blood | Colorectal Neoplasms - diagnosis | Adenoma, Villous - genetics | Aged, 80 and over | Adult | Female | CA-19-9 Antigen - blood | Urokinase-Type Plasminogen Activator - blood | Cathepsin L | Colorectal Neoplasms - blood | Urokinase-Type Plasminogen Activator - genetics | Biomarkers, Tumor - blood | Cathepsins - genetics | Cysteine Endopeptidases - genetics | Adenoma, Villous - pathology | Cathepsin B - blood | Survival Analysis | Aged | Biomarkers, Tumor - genetics | Colorectal Neoplasms - pathology | Cysteine Endopeptidases - blood | Usage | Tumor markers | Colorectal cancer | Cathepsins | Physiological aspects | Genetic aspects | Research | Health aspects | Risk factors | Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 05/2011, Volume 30, Issue 21, pp. 2401 - 2410
cervical cancer | miR-23b | HPV-16 E6 | uPA | p53 | Biochemistry & Molecular Biology | Oncology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Fundamental and applied biological sciences. Psychology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Cell physiology | Molecular and cellular biology | Medical sciences | Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes | Female genital diseases | Tumors | Human papillomavirus 16 - physiology | Humans | Gene Expression Regulation, Neoplastic | 3' Untranslated Regions - genetics | MicroRNAs - metabolism | Uterine Cervical Neoplasms - pathology | Tumor Suppressor Protein p53 - genetics | Repressor Proteins - physiology | RNA Interference | Female | Oncogene Proteins, Viral - genetics | Oncogene Proteins, Viral - physiology | Signal Transduction | Tumor Suppressor Protein p53 - metabolism | Repressor Proteins - genetics | Urokinase-Type Plasminogen Activator - genetics | Reverse Transcriptase Polymerase Chain Reaction | Uterine Cervical Neoplasms - genetics | Blotting, Western | Host-Pathogen Interactions - genetics | Urokinase-Type Plasminogen Activator - metabolism | Gene Expression Regulation, Viral | Cell Line, Tumor | Uterine Cervical Neoplasms - virology | MicroRNAs - genetics | Human papillomavirus 16 - genetics | Cell Movement | Papillomaviruses | Physiological aspects | Development and progression | Genetic aspects | Research | Metastasis | Cervical cancer | Cell migration | Proteins | Human papillomavirus | Ribonucleic acid--RNA | Gene expression | Index Medicus
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 02/2015, Volume 290, Issue 9, pp. 5241 - 5255
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Up-Regulation | Humans | Epithelial Sodium Channels - metabolism | Sodium - metabolism | Ion Channel Gating - physiology | Epithelial Sodium Channels - genetics | Plasminogen Activator Inhibitor 1 - metabolism | Proteolysis | Female | Urokinase-Type Plasminogen Activator - chemistry | Plasminogen Activator Inhibitor 1 - genetics | Protein Structure, Tertiary | Catalytic Domain | Oocytes - metabolism | Xenopus laevis | Models, Molecular | Binding Sites - genetics | Urokinase-Type Plasminogen Activator - genetics | Epithelial Sodium Channels - chemistry | Blotting, Western | Patch-Clamp Techniques | Animals | Ion Channel Gating - genetics | Oocytes - physiology | Plasminogen Activator Inhibitor 1 - chemistry | Urokinase-Type Plasminogen Activator - metabolism | Protein Binding | Kinetics | Mutation | Index Medicus | Plasma Membrane | Epithelial Sodium Channel (ENaC) | Membrane Biology | Enzyme Catalysis | Gel Electrophoresis | Electrophysiology
Journal Article
BMC evolutionary biology, ISSN 1471-2148, 01/2019, Volume 19, Issue 1, pp. 27 - 27
Phylogenetic analysis | Evolution | Transcriptome analysis | Chordates | Plasminogen | Plasminogen activation system | Genetics & Heredity | Life Sciences & Biomedicine | Evolutionary Biology | Science & Technology | Chordata - genetics | Amino Acid Sequence | Humans | Plasminogen - genetics | Transcriptome - genetics | Phylogeny | Genetic Variation | Likelihood Functions | Animals | Plasminogen Activator Inhibitor 1 - chemistry | Sequence Analysis, RNA | Databases, Protein | Vitronectin - chemistry | Protein Domains | Urokinase-Type Plasminogen Activator - chemistry | Reptiles | Genes | Serine | Biological evolution | Vitronectin | Evolutionary genetics | Activation | Genomes | Plasmin | t-Plasminogen activator | Proteins | Urokinase | Hyaluronan | Proteolysis | Phylogenetics | Physiology | Bioinformatics | Growth factors | Enzymes | Mammals | Diversification | U-Plasminogen activator | Vertebrates | Protease inhibitors | Surveillance | Plasminogen activator inhibitors | Serine proteinase | Hyaluronic acid | Binding sites | Index Medicus
Journal Article
The European journal of neuroscience, ISSN 0953-816X, 03/2017, Volume 45, Issue 6, pp. 805 - 815
urokinase‐type plasminogen activator | circadian rhythms | suprachiasmatic nucleus | tissue‐type plasminogen activator | urokinase-type plasminogen activator | tissue-type plasminogen activator | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Brain-Derived Neurotrophic Factor - genetics | Suprachiasmatic Nucleus - drug effects | Tissue Plasminogen Activator - metabolism | Mice, Inbred C57BL | Plasminogen Inactivators - pharmacology | Male | Tissue Plasminogen Activator - genetics | Suprachiasmatic Nucleus - physiology | Animals | Urokinase-Type Plasminogen Activator - metabolism | Proteolysis | Circadian Clocks | Female | Suprachiasmatic Nucleus - metabolism | Brain-Derived Neurotrophic Factor - metabolism | Mice | Urokinase | Glutamate | Tissue plasminogen activator | Laws, regulations and rules | Suprachiasmatic nucleus | Glutamic acid | Brain | Night | Glutamic acid receptors (ionotropic) | Brain slice preparation | Nuclei | Phase transitions | Plasmin | t-Plasminogen activator | Receptors | Casein | Rodents | Entrainment | Inhibition | Biological clocks | Circadian rhythms | Phase shift | Polyamide-imides | N-Methyl-D-aspartic acid receptors | Circadian rhythm | Mammals | U-Plasminogen activator | Brain-derived neurotrophic factor | Inhibitors | Plasminogen activator inhibitors | TrkB receptors | Glutamatergic transmission | Gates | Index Medicus
Journal Article